NVCT
Nuvectis Pharma Inc.
$6.08
+$0.20(+3.40%)
25
Overall
40
Value
10
Tech
--
Quality
Market Cap
$169.83M
Volume
78.53K
52W Range
$4.44 - $11.52
Target Price
$18.00
Latest News for NVCT
Maxim Group Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)
TipRanks Auto-Generated Intelligence Newsdesk•18 days ago•Nov 05, 2025
Maxim Group analyst Naz Rahman reiterated a Buy rating on Nuvectis Pharma yesterday and set a price target of $17.00. According to TipRanks, Rahman......
Roth MKM Sticks to Its Buy Rating for Nuvectis Pharma (NVCT)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago•Oct 28, 2025
Roth MKM analyst maintained a Buy rating on Nuvectis Pharma today and set a price target of $20.00. The company’s shares opened today at $6.61. Nuv......
Nuvectis Pharma’s Phase 1 Study of NXP900: A Potential Game-Changer in Cancer Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdesk•a month ago•Oct 27, 2025
Nuvectis Pharma, Inc. (($NVCT)) announced an update on their ongoing clinical study. Nuvectis Pharma, Inc. is currently conducting a Phase 1 clinic......
News data is sourced from MarketXLS API and updated regularly.
Showing 3 of 3 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVCT | $6.08 | +3.4% | 78.53K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |